Francine M. Foss, MD

Specialty

Internal Medicine, Medical Oncology

Conditions & Treatments

Bone Marrow Stem Cell Transplants, Bone Marrow Transplant, Cancer, Cancer Clinical Trials, Cutaneous T-Cell Lymphoma, Graft vs Host Disease, Hematologic Disorders, Hodgkin's Disease, Leukemia, Lymphoma, Multiple Myeloma, Stem Cell Transplantation


Phone
(203) 200-4363
Accepting New Patients

Biography

Francine Foss, MD, professor of medicine in the Section of Medical Oncology at the Yale Cancer Center, is an internationally recognized clinician and clinical researcher with expertise in adult lymphomas and in stem cell allotransplantation. She has derived and tested therapies that have been used to treat thousands of cancer patients, and her research has potential to substantially impact the field of stem cell research, benefiting patients at Yale and around the world. Dr Foss has brought a nationally established clinical trials program to the Yale Cancer Center.

In her previous post at Tufts New England Medical Center in Boston, she designed, initiated and directed multi-center national clinical trials which led to FDA approval of several novel therapies for lymphomas. One of these, Interleukin-2 conjugated to Diphtheria toxin, was the first FDA-approved fusion biologic drug to be approved for use in the United States. She also developed a treatment for patients undergoing allogeneic stem cell transplant that reduced the development of graft-versus-host disease. These findings led to the initiation of two National Cancer Institute-sponsored trials to confirm these results in patients with lymphoma and myelodysplastic syndrome.

Dr Foss is a world expert in T cell Lymphomas. She has pioneered several novel therapies for T cell lymphomas and has led a number of national studies. She is currently overseeing a national registry for T cell lymphomas and is a founder and co-chairman of the T CELL Forum, the preeminent international T cell lymphoma research meeting. She is a founder of the United States Cutaneous Lymphoma Consortium and the Peripheral T cell Consortium. She has been a translational researcher in T cell Lymphomas and currently is collaborating with a number of laboratories at Yale to identify molecular targets in T cell Lymphoma.

Gender

Female

Language(s)

English

Years In Practice

37

Affiliated With

Smilow Cancer Hospital, Yale Medicine

Locations

Smilow Cancer Hospital

35 Park St.
New Haven, CT 06519

Get Directions

Monday8:30 AM - 5:00 PM
Tuesday8:30 AM - 5:00 PM
Wednesday8:30 AM - 5:00 PM
Thursday8:30 AM - 5:00 PM
Friday8:30 AM - 5:00 PM
Fax
(203) 200-2429

Education & Training

Education

University of Massachusetts Medical School

Residency

Brigham and Women's Hospital

Fellowship

National Cancer Institute

Accepted Insurance

Insurance coverage regularly changes, please contact the doctor’s office directly to verify that your specific insurance plan is accepted.

  • aetna
  • anthem bc/bs
  • berkeley care network
  • cigna healthcare
  • community care network
  • connecticare
  • corvel
  • first health network
  • focus healthcare
  • great west
  • husky
  • medicaid
  • medicare
  • multiplan
  • oxford health plans
  • railroad medicare
  • tricare/champus
  • united healthcare
  • us family health plan
  • wellcare